Baidu's founder-backed BioMap confidentially files for Hong Kong IPO: Bloomberg

BioMap, a US-based biotech firm set up by China's search engine giant Baidu's (9888) founder Robin Li Yanhong, has confidentially filed for an initial public offering in Hong Kong, Bloomberg reported.

The company could raise hundreds of millions of US dollars from the listing that could take place as early as this year, the report said, citing people familiar with the matter.

It is reported that BioMap is working with China International Capital Corp (3908), Morgan Stanley, and UBS for the share sale, though the size and timing of the listing are not yet finalized.

Government-owned Hong Kong Investment Corporation is one of the investors of BioMap.